Table 1 Subject characteristics based on treatment groups
Characteristics | Non-concentrated ADSC-CM (n = 17) | Concentrated ADSC-CM (n = 20) |
|---|---|---|
Age (years) | 36.05 ± 6.02 | 37.40 ± 10.35 |
Weight (kg) | 77.52 ± 14.86 | 78.5 ± 12.55 |
Height (cm) | 170.71 ± 6.41 | 171.85 ± 6.36 |
Waist circumference (cm) | 93.82 ± 13.53 | 97.70 ± 15.30 |
BMI (kg/m2) | 26.57 ± 4.04 | 26.45 ± 4.01 |
Hamilton–Norwood grade | ||
 III | 2 (11.8) | 1 (5.0) |
 III vertex | 1 (5.9) | 3 (15.0) |
 IV | 2 (11.8) | 2 (10.0 |
 IVa | 3 (17.6) | 5 (25.0) |
 V | 2 (11.8) | 2 (10.0) |
 Va | 2 (11.8) | 3 (15.0) |
 VI | 5 (29.4) | 4 (20.0) |
Onset of alopecia (years) | 7.67 ± 5.00 | 6.35 ± 3.11 |
Family history of alopecia | ||
 No history | 2 (11.8) | 3 (15.0) |
 Maternal | 7 (41.1) | 7 (35.0) |
 Paternal | 3 (8.1) | 8 (40.0) |
 Others | 10 (27.0) | 8 (40.0) |
 Multiple family members | 5 (13.5) | 8 (40.0) |
Medical history | ||
 Hypertension | 4 (23.5) | 3 (15.0) |
 Dyslipidemia | 4 (23.5) | 6 (30.0) |
 COVID-19 | 3 (17.6) | 5 (25.0) |
 Smoking status | 5 (29.4) | 4 (20.0) |
Current complaints | ||
 No symptoms | 2 (5.4) | 1 (5.0) |
 Cosmetic disturbance | 14 (82.3) | 13 (65.0) |
 Low self-esteem | 1 (5.9) | 4 (20.0) |
 Itch | 11 (64.7) | 10 (50.0) |
 Others | 16 (94.1) | 10 (50.0) |
Previous therapy for alopecia | ||
 No therapy | 4 (23.5) | 6 (30.0) |
 Topical minoxidil | 6 (35.2) | 6 (30.0) |
 Non-pharmaceutical agents | 9 (52.9) | 8 (40.0) |
 Oral finasteride | 3 (17.6) | 1 (5.0) |
 Surgical intervention | 2 (11.7) | 1 (5.0) |
 Others | 3 (17.6) | 3 (15.0) |
Current medication history | ||
 No medication | 9 (52.9) | 9 (45.0) |
 Systemic medication | 5 (29.4) | 7 (35.0) |
 Vitamins, supplements | 2 (5.4) | 4 (20.0) |
 Others | 1 (5.9) | 2 (10.0) |